Clinical Trial Screen Failure Calculator
Calculate retrospective failure rates or project screening requirements for study planning.
Analysis Result:
How to Calculate Screen Failure Rate in Clinical Trials
In clinical research, the Screen Failure Rate (SFR) is a critical Key Performance Indicator (KPI) used to assess recruitment feasibility, budget planning, and timeline management. It represents the percentage of potential participants who sign an informed consent form (ICF) but are subsequently deemed ineligible or withdraw before randomization/enrollment.
Accurately calculating this rate allows sponsors and Contract Research Organizations (CROs) to estimate the total workload required to achieve the target sample size. Underestimating screen failures can lead to significant budget overruns and study delays.
The Screen Failure Rate Formula
The standard formula to calculate the screen failure rate based on existing data is:
Where:
- Screened: The total count of subjects who signed the informed consent form.
- Enrolled: The count of subjects who met all inclusion/exclusion criteria and were randomized into the study.
Example Calculation
If a site screens 20 subjects and only 5 are randomized:
- Screen Failures = 20 – 5 = 15 subjects.
- Rate = (15 / 20) × 100 = 75% Screen Failure Rate.
Projecting Screening Requirements
Before a study begins, project managers must calculate how many subjects need to be screened to hit the enrollment target. This is done using the inverse of the success rate.
If you need 100 randomized patients and the estimated failure rate is 60%:
- Success Rate = 1 – 0.60 = 0.40 (40%)
- Required Screened = 100 / 0.40 = 250 subjects.
This means you must budget for the costs of screening 250 patients (lab tests, visits, staff time) to achieve your goal.
Common Causes of High Screen Failure Rates
Understanding why rates are high is as important as the calculation. Common factors include:
- Restrictive I/E Criteria: Inclusion/exclusion criteria that are too narrow for the patient population.
- Protocol Complexity: Demanding procedures that cause patient withdrawal during screening.
- Washout Periods: Patients unable to stop current medications safely.
- Diagnostic Failures: Biomarker or lab values falling outside the specified range.
Budgetary Implications
Screen failures are not free. Sponsors typically pay a "screen failure fee" to sites for the work performed, or the costs are absorbed into the per-patient grant. A higher-than-expected SFR directly increases the Cost Per Randomized Subject.
'; html += '
'; html += '